Hexokinase II Antibody - #DF6176
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# DF6176, RRID:AB_2838143.
折りたたみ/展開
DKFZp686M1669; Hexokinase 2; Hexokinase 2 muscle; Hexokinase type II; Hexokinase-2; HK 2; HK II; HK2; HKII; HxK 2; HxK2; HXK2_HUMAN; Muscle form hexokinase;
免疫原
Predominant hexokinase isozyme expressed in insulin-responsive tissues such as skeletal muscle.
- P52789 HXK2_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MIASHLLAYFFTELNHDQVQKVDQYLYHMRLSDETLLEISKRFRKEMEKGLGATTHPTAAVKMLPTFVRSTPDGTEHGEFLALDLGGTNFRVLWVKVTDNGLQKVEMENQIYAIPEDIMRGSGTQLFDHIAECLANFMDKLQIKDKKLPLGFTFSFPCHQTKLDESFLVSWTKGFKSSGVEGRDVVALIRKAIQRRGDFDIDIVAVVNDTVGTMMTCGYDDHNCEIGLIVGTGSNACYMEEMRHIDMVEGDEGRMCINMEWGAFGDDGSLNDIRTEFDQEIDMGSLNPGKQLFEKMISGMYMGELVRLILVKMAKEELLFGGKLSPELLNTGRFETKDISDIEGEKDGIRKAREVLMRLGLDPTQEDCVATHRICQIVSTRSASLCAATLAAVLQRIKENKGEERLRSTIGVDGSVYKKHPHFAKRLHKTVRRLVPGCDVRFLRSEDGSGKGAAMVTAVAYRLADQHRARQKTLEHLQLSHDQLLEVKRRMKVEMERGLSKETHASAPVKMLPTYVCATPDGTEKGDFLALDLGGTNFRVLLVRVRNGKWGGVEMHNKIYAIPQEVMHGTGDELFDHIVQCIADFLEYMGMKGVSLPLGFTFSFPCQQNSLDESILLKWTKGFKASGCEGEDVVTLLKEAIHRREEFDLDVVAVVNDTVGTMMTCGFEDPHCEVGLIVGTGSNACYMEEMRNVELVEGEEGRMCVNMEWGAFGDNGCLDDFRTEFDVAVDELSLNPGKQRFEKMISGMYLGEIVRNILIDFTKRGLLFRGRISERLKTRGIFETKFLSQIESDCLALLQVRAILQHLGLESTCDDSIIVKEVCTVVARRAAQLCGAGMAAVVDRIRENRGLDALKVTVGVDGTLYKLHPHFAKVMHETVKDLAPKCDVSFLQSEDGSGKGAALITAVACRIREAGQR
種類予測
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - P52789 基板として
Site | PTM Type | Enzyme | Source |
---|---|---|---|
M1 | Acetylation | Uniprot | |
Y9 | Phosphorylation | Uniprot | |
K41 | Ubiquitination | Uniprot | |
K49 | Ubiquitination | Uniprot | |
K62 | Ubiquitination | Uniprot | |
K104 | Ubiquitination | Uniprot | |
Y112 | Phosphorylation | Uniprot | |
K147 | Ubiquitination | Uniprot | |
T153 | Phosphorylation | Uniprot | |
K173 | Ubiquitination | Uniprot | |
K176 | Ubiquitination | Uniprot | |
Y238 | Phosphorylation | Uniprot | |
K290 | Ubiquitination | Uniprot | |
Y301 | Phosphorylation | Uniprot | |
K315 | Ubiquitination | Uniprot | |
K323 | Ubiquitination | Uniprot | |
T331 | Phosphorylation | Uniprot | |
K337 | Ubiquitination | Uniprot | |
S340 | Phosphorylation | Uniprot | |
K346 | Ubiquitination | Uniprot | |
S384 | Phosphorylation | Uniprot | |
K401 | Ubiquitination | Uniprot | |
S415 | Phosphorylation | Uniprot | |
K418 | Ubiquitination | Uniprot | |
S445 | Phosphorylation | Uniprot | |
S449 | Phosphorylation | Uniprot | |
K451 | Ubiquitination | Uniprot | |
T457 | Phosphorylation | Uniprot | |
Y461 | Phosphorylation | Uniprot | |
K472 | Ubiquitination | Uniprot | |
T473 | Phosphorylation | Uniprot | |
K488 | Ubiquitination | Uniprot | |
K492 | Ubiquitination | Uniprot | |
K501 | Ubiquitination | Uniprot | |
S506 | Phosphorylation | Uniprot | |
K510 | Ubiquitination | Uniprot | |
T514 | Phosphorylation | Uniprot | |
K525 | Ubiquitination | Uniprot | |
K624 | Ubiquitination | Uniprot | |
K638 | Ubiquitination | Uniprot | |
Y686 | Phosphorylation | Uniprot | |
K738 | Ubiquitination | Uniprot | |
K743 | Ubiquitination | Uniprot | |
S746 | Phosphorylation | Uniprot | |
Y749 | Phosphorylation | Uniprot | |
T762 | Phosphorylation | Uniprot | |
K763 | Ubiquitination | Uniprot | |
K866 | Ubiquitination | Uniprot | |
K873 | Ubiquitination | Uniprot | |
K885 | Ubiquitination | Uniprot | |
S897 | Phosphorylation | Uniprot | |
K899 | Ubiquitination | Uniprot | |
T905 | Phosphorylation | Uniprot |
研究背景
Catalyzes the phosphorylation of hexose, such as D-glucose and D-fructose, to hexose 6-phosphate (D-glucose 6-phosphate and D-fructose 6-phosphate, respectively). Mediates the initial step of glycolysis by catalyzing phosphorylation of D-glucose to D-glucose 6-phosphate. Plays a key role in maintaining the integrity of the outer mitochondrial membrane by preventing the release of apoptogenic molecules from the intermembrane space and subsequent apoptosis.
Mitochondrion outer membrane>Peripheral membrane protein. Cytoplasm>Cytosol.
Note: The mitochondrial-binding peptide (MBP) region promotes association with the mitochondrial outer membrane (PubMed:29298880). The interaction with the mitochondrial outer membrane via the mitochondrial-binding peptide (MBP) region promotes higher stability of the protein (PubMed:29298880). Release from the mitochondrial outer membrane into the cytosol induces permeability transition pore (PTP) opening and apoptosis (PubMed:18350175).
Predominant hexokinase isozyme expressed in insulin-responsive tissues such as skeletal muscle.
Monomer (By similarity). Interacts with TIGAR; the interaction increases hexokinase activity in a hypoxia- and HIF1A-dependent manner.
The N- and C-terminal halves of the protein contain a hexokinase domain (PubMed:29298880). In contrast to hexokinase-1 and -3 (HK1 and HK3, respectively), both hexokinase domains display catalytic activity (PubMed:29298880). The region connecting the two hexokinase domains is required for the catalytic activity of the N-terminal hexokinase domain (PubMed:29298880). The N-terminal half regulates stability of the whole enzyme (PubMed:29298880).
Belongs to the hexokinase family.
研究領域
· Environmental Information Processing > Signal transduction > HIF-1 signaling pathway. (View pathway)
· Human Diseases > Endocrine and metabolic diseases > Type II diabetes mellitus.
· Human Diseases > Cancers: Overview > Central carbon metabolism in cancer. (View pathway)
· Metabolism > Carbohydrate metabolism > Glycolysis / Gluconeogenesis.
· Metabolism > Carbohydrate metabolism > Fructose and mannose metabolism.
· Metabolism > Carbohydrate metabolism > Galactose metabolism.
· Metabolism > Carbohydrate metabolism > Starch and sucrose metabolism.
· Metabolism > Carbohydrate metabolism > Amino sugar and nucleotide sugar metabolism.
· Metabolism > Biosynthesis of other secondary metabolites > Neomycin, kanamycin and gentamicin biosynthesis.
· Metabolism > Global and overview maps > Metabolic pathways.
· Metabolism > Global and overview maps > Carbon metabolism.
· Organismal Systems > Endocrine system > Insulin signaling pathway. (View pathway)
· Organismal Systems > Digestive system > Carbohydrate digestion and absorption.
参考文献
Application: WB Species: human Sample: MIA PaCa-2 cells
Application: WB Species: Human Sample: SHSY-5Y cells
Application: WB Species: Human Sample: MCF-7 cells
Application: WB Species: Mice Sample: GC cells
Application: WB Species: Mouse Sample: VFL epithelial cells
Application: IF/ICC Species: Mouse Sample: VFL epithelial cells
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.